Biodegradable chitosan microparticles induce delayed STAT-1 activation and lead to distinct cytokine responses in differentially polarized human macrophages in vitro
Source abstract
Abstract
Current data suggest that chitosan activates wound macrophages to release endogenous factors that guide mesenchymal stem cell (MSC) to bone fractures. We tested the hypothesis that chitosan, a polymer containing glucosamine and N-acetyl glucosamine, stimulates macrophages in different polarization states to release functional MSC chemokines and mainly anabolic factors. Low-serum conditioned medium was collected from M0, M1 and M2a U937 macrophages previously differentiated with phorbol myristate acetate (PMA) and exposed or not for 24h to chitosan microparticles (80% degree of deacetylation, DDA, 130kDa). Chitosan particles were highly phagocytosed. Chitosan enhanced anabolic factor release from M0 and M2a macrophages (MCP-1, IP-10, MIP-1beta, IL-1ra, IL-10, PDGF), and IL-1beta release, with 25- to 400-fold excess IL-1ra over IL-1beta. In M1 macrophages, chitosan enhanced IL-1beta without enhancing or suppressing inflammatory factor release (IL-6, IP-10, IL-8). M0 and M2a macrophages, with or without chitosan stimulation, produced conditioned medium that promoted 2-fold more MSC chemotaxis than low-serum control medium, while M1-conditioned medium failed to induce MSC chemotaxis. Acetylated chitosan induced U937 macrophages to release IL-1ra without STAT-6 activation, and also induced a delayed STAT-1 activation/IP-10 release response that was not observed using non-biodegradable chitosan (98% DDA, 130kDa). In primary human macrophages, acetylated chitosan enhanced IL-1ra release without inducing IL-1beta, and required PMA priming to elicit STAT-1 activation and IP-10 release. We conclude that biodegradable chitosan particles enhance M0 and M2a macrophage anabolic responses independent of the IL4/STAT-6 axis, by inducing excess IL-1ra over IL-1beta and more chemokine release, without altering their inherent capacity to attract MSCs.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Immune cells in cancer · Mesenchymal stem cell research · Wound Healing and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Mesenchymal stem cells and cartilage in situ regeneration10.1111/j.1365-2796.2009.02153.x ↗
2. Scaffold-guided subchondral bone repair: implication of neutrophils and alternatively activated arginase-1+ macrophages10.1177/0363546510369547 ↗
3. Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes10.1002/jor.1100180516 ↗
4. Chitosan–glycerol phosphate/blood implants improve hyaline cartilage repair in ovine microfracture defects10.2106/JBJS.D.02536 ↗
5. Chitosan–glycerol phosphate/blood implants increase cell recruitment, transient vascularization and subchondral bone remodeling in drilled cartilage defects. Osteoarthritis and cartilage/OARS10.1016/j.joca.2006.08.007 ↗
6. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives10.1016/S0142-9612(96)00167-6 ↗
7. Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation10.22203/eCM.v024a10 ↗
8. Evaluation effects of chitosan for the extracellular matrix production by fibroblasts and the growth factors production by macrophages10.1016/S0142-9612(00)00401-4 ↗
9. Biodegradable chitosan particles induce chemokine release and negligible arginase-1 activity compared to IL-4 in murine bone marrow-derived macrophages10.1016/j.bbrc.2011.01.063 ↗
10. Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis10.1074/jbc.M111.274936 ↗
11. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model10.1002/jbmr.354 ↗
12. Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state. Osteoarthritis and cartilage/OARS10.1016/j.joca.2014.05.021 ↗
13. Exploring the full spectrum of macrophage activation10.1038/nri2448 ↗
14. The chemokine system in diverse forms of macrophage activation and polarization10.1016/j.it.2004.09.015 ↗
15. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials10.1016/j.actbio.2011.11.031 ↗
16. Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion10.1371/journal.pone.0035036 ↗
17. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways10.1189/jlb.0908579 ↗
18. Macrophages modulate the viability and growth of human mesenchymal stem cells10.1002/jcb.24357 ↗
19. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin m signaling10.1002/stem.1040 ↗
20. The stimulation of an osteogenic response by classical monocyte activation10.1016/j.biomaterials.2011.07.055 ↗
21. Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation10.1371/journal.pone.0039871 ↗
22. Biodegradation of polycarbonate-based polyurethanes by the human monocytes-derived macrophage and U937 cell systems10.1002/jbm.10286 ↗
23. Interactions of U937 macrophage-like cells with decellularized pericardial matrix materials: influence of crosslinking treatment10.1016/j.actbio.2013.02.021 ↗
24. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation10.1016/j.biomaterials.2006.04.029 ↗
25. Precise derivatization of structurally distinct chitosans with rhodamine B isothiocyanate10.1016/j.carbpol.2007.10.004 ↗
26. A validated 1H NMR method for the determination of the degree of deacetylation of chitosan10.1016/S0731-7085(03)00155-9 ↗
27. Improved reproducibility in the determination of the molecular weight of chitosan by analytical size exclusion chromatography10.1016/j.carbpol.2008.08.013 ↗
28. Chitosan rate of uptake in HEK293 cells is influenced by soluble versus microparticle state and enhanced by serum-induced cell metabolism and lactate-based media acidification10.3390/molecules18011015 ↗
29. Response of macrophage-like U937 cells to decellularized tissue heart valve materials
30. Effects of chitin/chitosan and their oligomers/monomers on migrations of fibroblasts and vascular endothelium10.1016/S0142-9612(01)00324-6 ↗
31. Fibronectin, vitronectin, and collagen I induce chemotaxis and haptotaxis of human and rabbit mesenchymal stem cells in a standardized transmembrane assay10.1089/scd.2006.0100 ↗
32. Macrophage differentiation and polarization on a decellularized pericardial biomaterial10.1016/j.biomaterials.2010.09.004 ↗
33. In vitro response of macrophage polarization to a keratin biomaterial10.1016/j.actbio.2014.04.003 ↗
34. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages10.1016/j.jim.2011.10.013 ↗
35. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression10.4049/jimmunol.177.10.7303 ↗
36. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT610.4049/jimmunol.157.5.2058 ↗
37. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling10.1016/S1471-4906(01)02118-4 ↗
38. Foreign body-type multinucleated giant cell formation requires protein kinase C beta, delta, and zeta10.1016/j.yexmp.2007.10.005 ↗
39. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli10.1002/jlb.67.1.97 ↗
40. A high-throughput chemotaxis assay for pharmacological characterization of chemokine receptors: utilization of U937 monocytic cells10.1016/j.vascn.2004.10.001 ↗
41. Macrophage polarization following chitosan implantation10.1016/j.biomaterials.2013.09.012 ↗
42. Spectrum and mechanisms of inflammasome activation by chitosan10.4049/jimmunol.1301695 ↗
43. Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries10.1002/jbm.a.31863 ↗
44. The phenotype of murine wound macrophages10.1189/jlb.0409236 ↗
45. CSF-1 signal transduction10.1002/jlb.62.2.145 ↗
46. The catalytic domain of protein kinase C-delta in reciprocal delta and epsilon chimeras mediates phorbol ester-induced macrophage differentiation of mouse promyelocytes10.1074/jbc.272.1.76 ↗
47. Interleukin-10 suppresses IP-10 gene transcription by inhibiting the production of class I interferon10.1182/blood.V92.12.4742 ↗
48. Chemokine profile of human serum from whole blood: migratory effects of CXCL-10 and CXCL-11 on human mesenchymal stem cells10.3109/03008200903111906 ↗
49. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL210.1002/jcb.21172 ↗
50. Treatment of osteoarthritis with anakinra10.1007/s11926-007-0019-9 ↗
51. The localisation of inflammatory cells and expression of associated proteoglycans in response to implanted chitosan10.1016/j.biomaterials.2013.10.068 ↗
52. Evaluation of the effect of the degree of acetylation on the inflammatory response to 3D porous chitosan scaffolds10.1002/jbm.a.32499 ↗
53. Subchondral pre-solidified chitosan/blood implants elicit reproducible early osteochondral wound-repair responses including neutrophil and stromal cell chemotaxis, bone resorption and repair, enhanced repair tissue integration and delayed matrix deposition10.1186/1471-2474-14-27 ↗
54. Chitin induces accumulation in tissue of innate immune cells associated with allergy10.1038/nature05746 ↗
55. Wagoner Johnson AJ. The effect of chitosan on the migration of neutrophil-like HL60 cells, mediated by IL-810.1016/j.biomaterials.2008.09.060 ↗
56. Chitin and chitosan stimulate canine polymorphonuclear cells to release leukotriene B4 and prostaglandin E210.1002/(SICI)1097-4636(19981215)42:4<517::AID-JBM6>3.0.CO;2-U ↗